Global Precision Cancer Tests Market Size, Status and Forecast 2024-2031

Report ID: 917706 | Published Date: Dec 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Precision Cancer Tests Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Imaging
        1.2.3 In Vitro Diagnostic
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Precision Cancer Tests Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Cancer Research Centers
        1.3.3 Cancer Hospital
        1.3.4 Surgical Centers
        1.3.5 Clinics
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Precision Cancer Tests Market Perspective (2016-2027)
    2.2 Precision Cancer Tests Growth Trends by Regions
        2.2.1 Precision Cancer Tests Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Precision Cancer Tests Historic Market Share by Regions (2016-2021)
        2.2.3 Precision Cancer Tests Forecasted Market Size by Regions (2022-2027)
    2.3 Precision Cancer Tests Industry Dynamic
        2.3.1 Precision Cancer Tests Market Trends
        2.3.2 Precision Cancer Tests Market Drivers
        2.3.3 Precision Cancer Tests Market Challenges
        2.3.4 Precision Cancer Tests Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Precision Cancer Tests Players by Revenue
        3.1.1 Global Top Precision Cancer Tests Players by Revenue (2016-2021)
        3.1.2 Global Precision Cancer Tests Revenue Market Share by Players (2016-2021)
    3.2 Global Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Precision Cancer Tests Revenue
    3.4 Global Precision Cancer Tests Market Concentration Ratio
        3.4.1 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Tests Revenue in 2020
    3.5 Precision Cancer Tests Key Players Head office and Area Served
    3.6 Key Players Precision Cancer Tests Product Solution and Service
    3.7 Date of Enter into Precision Cancer Tests Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Cancer Tests Breakdown Data by Type
    4.1 Global Precision Cancer Tests Historic Market Size by Type (2016-2021)
    4.2 Global Precision Cancer Tests Forecasted Market Size by Type (2022-2027)

5 Precision Cancer Tests Breakdown Data by Application
    5.1 Global Precision Cancer Tests Historic Market Size by Application (2016-2021)
    5.2 Global Precision Cancer Tests Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Precision Cancer Tests Market Size (2016-2027)
    6.2 North America Precision Cancer Tests Market Size by Type
        6.2.1 North America Precision Cancer Tests Market Size by Type (2016-2021)
        6.2.2 North America Precision Cancer Tests Market Size by Type (2022-2027)
        6.2.3 North America Precision Cancer Tests Market Size by Type (2016-2027)
    6.3 North America Precision Cancer Tests Market Size by Application
        6.3.1 North America Precision Cancer Tests Market Size by Application (2016-2021)
        6.3.2 North America Precision Cancer Tests Market Size by Application (2022-2027)
        6.3.3 North America Precision Cancer Tests Market Size by Application (2016-2027)
    6.4 North America Precision Cancer Tests Market Size by Country
        6.4.1 North America Precision Cancer Tests Market Size by Country (2016-2021)
        6.4.2 North America Precision Cancer Tests Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Precision Cancer Tests Market Size (2016-2027)
    7.2 Europe Precision Cancer Tests Market Size by Type
        7.2.1 Europe Precision Cancer Tests Market Size by Type (2016-2021)
        7.2.2 Europe Precision Cancer Tests Market Size by Type (2022-2027)
        7.2.3 Europe Precision Cancer Tests Market Size by Type (2016-2027)
    7.3 Europe Precision Cancer Tests Market Size by Application
        7.3.1 Europe Precision Cancer Tests Market Size by Application (2016-2021)
        7.3.2 Europe Precision Cancer Tests Market Size by Application (2022-2027)
        7.3.3 Europe Precision Cancer Tests Market Size by Application (2016-2027)
    7.4 Europe Precision Cancer Tests Market Size by Country
        7.4.1 Europe Precision Cancer Tests Market Size by Country (2016-2021)
        7.4.2 Europe Precision Cancer Tests Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Precision Cancer Tests Market Size (2016-2027)
    8.2 Asia-Pacific Precision Cancer Tests Market Size by Type
        8.2.1 Asia-Pacific Precision Cancer Tests Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Precision Cancer Tests Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Precision Cancer Tests Market Size by Type (2016-2027)
    8.3 Asia-Pacific Precision Cancer Tests Market Size by Application
        8.3.1 Asia-Pacific Precision Cancer Tests Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Precision Cancer Tests Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Precision Cancer Tests Market Size by Application (2016-2027)
    8.4 Asia-Pacific Precision Cancer Tests Market Size by Region
        8.4.1 Asia-Pacific Precision Cancer Tests Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Precision Cancer Tests Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Precision Cancer Tests Market Size (2016-2027)
    9.2 Latin America Precision Cancer Tests Market Size by Type
        9.2.1 Latin America Precision Cancer Tests Market Size by Type (2016-2021)
        9.2.2 Latin America Precision Cancer Tests Market Size by Type (2022-2027)
        9.2.3 Latin America Precision Cancer Tests Market Size by Type (2016-2027)
    9.3 Latin America Precision Cancer Tests Market Size by Application
        9.3.1 Latin America Precision Cancer Tests Market Size by Application (2016-2021)
        9.3.2 Latin America Precision Cancer Tests Market Size by Application (2022-2027)
        9.3.3 Latin America Precision Cancer Tests Market Size by Application (2016-2027)
    9.4 Latin America Precision Cancer Tests Market Size by Country
        9.4.1 Latin America Precision Cancer Tests Market Size by Country (2016-2021)
        9.4.2 Latin America Precision Cancer Tests Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Precision Cancer Tests Market Size (2016-2027)
    10.2 Middle East & Africa Precision Cancer Tests Market Size by Type
        10.2.1 Middle East & Africa Precision Cancer Tests Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Precision Cancer Tests Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Precision Cancer Tests Market Size by Type (2016-2027)
    10.3 Middle East & Africa Precision Cancer Tests Market Size by Application
        10.3.1 Middle East & Africa Precision Cancer Tests Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Precision Cancer Tests Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Precision Cancer Tests Market Size by Application (2016-2027)
    10.4 Middle East & Africa Precision Cancer Tests Market Size by Country
        10.4.1 Middle East & Africa Precision Cancer Tests Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Precision Cancer Tests Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Precision Cancer Tests Introduction
        11.1.4 Abbott Revenue in Precision Cancer Tests Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 BD
        11.2.1 BD Company Details
        11.2.2 BD Business Overview
        11.2.3 BD Precision Cancer Tests Introduction
        11.2.4 BD Revenue in Precision Cancer Tests Business (2016-2021)
        11.2.5 BD Recent Development
    11.3 Bio-Rad
        11.3.1 Bio-Rad Company Details
        11.3.2 Bio-Rad Business Overview
        11.3.3 Bio-Rad Precision Cancer Tests Introduction
        11.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2016-2021)
        11.3.5 Bio-Rad Recent Development
    11.4 Cynvenio Biosystems
        11.4.1 Cynvenio Biosystems Company Details
        11.4.2 Cynvenio Biosystems Business Overview
        11.4.3 Cynvenio Biosystems Precision Cancer Tests Introduction
        11.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2016-2021)
        11.4.5 Cynvenio Biosystems Recent Development
    11.5 Foundation Medicine
        11.5.1 Foundation Medicine Company Details
        11.5.2 Foundation Medicine Business Overview
        11.5.3 Foundation Medicine Precision Cancer Tests Introduction
        11.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2016-2021)
        11.5.5 Foundation Medicine Recent Development
    11.6 Genomic Health
        11.6.1 Genomic Health Company Details
        11.6.2 Genomic Health Business Overview
        11.6.3 Genomic Health Precision Cancer Tests Introduction
        11.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2016-2021)
        11.6.5 Genomic Health Recent Development
    11.7 Illumina
        11.7.1 Illumina Company Details
        11.7.2 Illumina Business Overview
        11.7.3 Illumina Precision Cancer Tests Introduction
        11.7.4 Illumina Revenue in Precision Cancer Tests Business (2016-2021)
        11.7.5 Illumina Recent Development
    11.8 Myriad Genetics
        11.8.1 Myriad Genetics Company Details
        11.8.2 Myriad Genetics Business Overview
        11.8.3 Myriad Genetics Precision Cancer Tests Introduction
        11.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2016-2021)
        11.8.5 Myriad Genetics Recent Development
    11.9 NanoString Technologies
        11.9.1 NanoString Technologies Company Details
        11.9.2 NanoString Technologies Business Overview
        11.9.3 NanoString Technologies Precision Cancer Tests Introduction
        11.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2016-2021)
        11.9.5 NanoString Technologies Recent Development
    11.10 QIAGEN
        11.10.1 QIAGEN Company Details
        11.10.2 QIAGEN Business Overview
        11.10.3 QIAGEN Precision Cancer Tests Introduction
        11.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2016-2021)
        11.10.5 QIAGEN Recent Development
    11.11 Randox Laboratories
        11.11.1 Randox Laboratories Company Details
        11.11.2 Randox Laboratories Business Overview
        11.11.3 Randox Laboratories Precision Cancer Tests Introduction
        11.11.4 Randox Laboratories Revenue in Precision Cancer Tests Business (2016-2021)
        11.11.5 Randox Laboratories Recent Development
    11.12 Roche
        11.12.1 Roche Company Details
        11.12.2 Roche Business Overview
        11.12.3 Roche Precision Cancer Tests Introduction
        11.12.4 Roche Revenue in Precision Cancer Tests Business (2016-2021)
        11.12.5 Roche Recent Development
    11.13 Philips
        11.13.1 Philips Company Details
        11.13.2 Philips Business Overview
        11.13.3 Philips Precision Cancer Tests Introduction
        11.13.4 Philips Revenue in Precision Cancer Tests Business (2016-2021)
        11.13.5 Philips Recent Development
    11.14 Thermo Fisher Scientific
        11.14.1 Thermo Fisher Scientific Company Details
        11.14.2 Thermo Fisher Scientific Business Overview
        11.14.3 Thermo Fisher Scientific Precision Cancer Tests Introduction
        11.14.4 Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2016-2021)
        11.14.5 Thermo Fisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Precision Cancer Tests Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Imaging
    Table 3. Key Players of In Vitro Diagnostic
    Table 4. Key Players of Others
    Table 5. Global Precision Cancer Tests Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Precision Cancer Tests Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Precision Cancer Tests Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Precision Cancer Tests Market Share by Regions (2016-2021)
    Table 9. Global Precision Cancer Tests Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Precision Cancer Tests Market Share by Regions (2022-2027)
    Table 11. Precision Cancer Tests Market Trends
    Table 12. Precision Cancer Tests Market Drivers
    Table 13. Precision Cancer Tests Market Challenges
    Table 14. Precision Cancer Tests Market Restraints
    Table 15. Global Precision Cancer Tests Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Precision Cancer Tests Market Share by Players (2016-2021)
    Table 17. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Tests as of 2020)
    Table 18. Ranking of Global Top Precision Cancer Tests Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Precision Cancer Tests Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Precision Cancer Tests Product Solution and Service
    Table 22. Date of Enter into Precision Cancer Tests Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Precision Cancer Tests Revenue Market Share by Type (2016-2021)
    Table 26. Global Precision Cancer Tests Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Precision Cancer Tests Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Precision Cancer Tests Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Precision Cancer Tests Revenue Market Share by Application (2016-2021)
    Table 30. Global Precision Cancer Tests Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Precision Cancer Tests Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Precision Cancer Tests Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Precision Cancer Tests Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Precision Cancer Tests Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Precision Cancer Tests Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Precision Cancer Tests Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Precision Cancer Tests Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Precision Cancer Tests Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Precision Cancer Tests Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Precision Cancer Tests Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Precision Cancer Tests Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Abbott Company Details
    Table 63. Abbott Business Overview
    Table 64. Abbott Precision Cancer Tests Product
    Table 65. Abbott Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 66. Abbott Recent Development
    Table 67. BD Company Details
    Table 68. BD Business Overview
    Table 69. BD Precision Cancer Tests Product
    Table 70. BD Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 71. BD Recent Development
    Table 72. Bio-Rad Company Details
    Table 73. Bio-Rad Business Overview
    Table 74. Bio-Rad Precision Cancer Tests Product
    Table 75. Bio-Rad Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 76. Bio-Rad Recent Development
    Table 77. Cynvenio Biosystems Company Details
    Table 78. Cynvenio Biosystems Business Overview
    Table 79. Cynvenio Biosystems Precision Cancer Tests Product
    Table 80. Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 81. Cynvenio Biosystems Recent Development
    Table 82. Foundation Medicine Company Details
    Table 83. Foundation Medicine Business Overview
    Table 84. Foundation Medicine Precision Cancer Tests Product
    Table 85. Foundation Medicine Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 86. Foundation Medicine Recent Development
    Table 87. Genomic Health Company Details
    Table 88. Genomic Health Business Overview
    Table 89. Genomic Health Precision Cancer Tests Product
    Table 90. Genomic Health Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 91. Genomic Health Recent Development
    Table 92. Illumina Company Details
    Table 93. Illumina Business Overview
    Table 94. Illumina Precision Cancer Tests Product
    Table 95. Illumina Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 96. Illumina Recent Development
    Table 97. Myriad Genetics Company Details
    Table 98. Myriad Genetics Business Overview
    Table 99. Myriad Genetics Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 100. Myriad Genetics Recent Development
    Table 101. NanoString Technologies Company Details
    Table 102. NanoString Technologies Business Overview
    Table 103. NanoString Technologies Precision Cancer Tests Product
    Table 104. NanoString Technologies Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 105. NanoString Technologies Recent Development
    Table 106. QIAGEN Company Details
    Table 107. QIAGEN Business Overview
    Table 108. QIAGEN Precision Cancer Tests Product
    Table 109. QIAGEN Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 110. QIAGEN Recent Development
    Table 111. Randox Laboratories Company Details
    Table 112. Randox Laboratories Business Overview
    Table 113. Randox Laboratories Precision Cancer Tests Product
    Table 114. Randox Laboratories Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 115. Randox Laboratories Recent Development
    Table 116. Roche Company Details
    Table 117. Roche Business Overview
    Table 118. Roche Precision Cancer Tests Product
    Table 119. Roche Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 120. Roche Recent Development
    Table 121. Philips Company Details
    Table 122. Philips Business Overview
    Table 123. Philips Precision Cancer Tests Product
    Table 124. Philips Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 125. Philips Recent Development
    Table 126. Thermo Fisher Scientific Company Details
    Table 127. Thermo Fisher Scientific Business Overview
    Table 128. Thermo Fisher Scientific Precision Cancer Tests Product
    Table 129. Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million)
    Table 130. Thermo Fisher Scientific Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Precision Cancer Tests Market Share by Type: 2020 VS 2027
    Figure 2. Imaging Features
    Figure 3. In Vitro Diagnostic Features
    Figure 4. Others Features
    Figure 5. Global Precision Cancer Tests Market Share by Application: 2020 VS 2027
    Figure 6. Cancer Research Centers Case Studies
    Figure 7. Cancer Hospital Case Studies
    Figure 8. Surgical Centers Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Precision Cancer Tests Report Years Considered
    Figure 12. Global Precision Cancer Tests Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Precision Cancer Tests Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Precision Cancer Tests Market Share by Regions: 2020 VS 2027
    Figure 15. Global Precision Cancer Tests Market Share by Regions (2022-2027)
    Figure 16. Global Precision Cancer Tests Market Share by Players in 2020
    Figure 17. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Tests as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Tests Revenue in 2020
    Figure 19. Global Precision Cancer Tests Revenue Market Share by Type (2016-2021)
    Figure 20. Global Precision Cancer Tests Revenue Market Share by Type (2022-2027)
    Figure 21. North America Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Precision Cancer Tests Market Share by Type (2016-2027)
    Figure 23. North America Precision Cancer Tests Market Share by Application (2016-2027)
    Figure 24. North America Precision Cancer Tests Market Share by Country (2016-2027)
    Figure 25. United States Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Precision Cancer Tests Market Share by Type (2016-2027)
    Figure 29. Europe Precision Cancer Tests Market Share by Application (2016-2027)
    Figure 30. Europe Precision Cancer Tests Market Share by Country (2016-2027)
    Figure 31. Germany Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Precision Cancer Tests Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Precision Cancer Tests Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Precision Cancer Tests Market Share by Region (2016-2027)
    Figure 41. China Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Precision Cancer Tests Market Share by Type (2016-2027)
    Figure 49. Latin America Precision Cancer Tests Market Share by Application (2016-2027)
    Figure 50. Latin America Precision Cancer Tests Market Share by Country (2016-2027)
    Figure 51. Mexico Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Precision Cancer Tests Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Precision Cancer Tests Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Precision Cancer Tests Market Share by Country (2016-2027)
    Figure 57. Turkey Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Abbott Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 61. BD Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 62. Bio-Rad Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 63. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 64. Foundation Medicine Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 65. Genomic Health Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 66. Illumina Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 67. Myriad Genetics Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 68. NanoString Technologies Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 69. QIAGEN Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 70. Randox Laboratories Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 71. Roche Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 72. Philips Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 73. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Tests Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Frequently Asked Questions
Precision Cancer Tests report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Precision Cancer Tests report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Precision Cancer Tests report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports